Paradoxical reaction to rituximab in patients with pemphigus : a report of 10 cases
| Errataetall: |
CommentOn: Int Immunopharmacol. 2019 Jun;71:40-42. - PMID 30877872 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Immunopharmacology and immunotoxicology - 42(2020), 1 vom: 01. Feb., Seite 56-58 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nili, Ali [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4F4X42SYQ6 |
|---|
| Anmerkungen: |
Date Completed 25.03.2020 Date Revised 25.03.2020 published: Print-Electronic CommentOn: Int Immunopharmacol. 2019 Jun;71:40-42. - PMID 30877872 Citation Status MEDLINE |
|---|
| doi: |
10.1080/08923973.2020.1717526 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305833480 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305833480 | ||
| 003 | DE-627 | ||
| 005 | 20231225122033.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/08923973.2020.1717526 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1019.xml |
| 035 | |a (DE-627)NLM305833480 | ||
| 035 | |a (NLM)31986931 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nili, Ali |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Paradoxical reaction to rituximab in patients with pemphigus |b a report of 10 cases |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2020 | ||
| 500 | |a Date Revised 25.03.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Int Immunopharmacol. 2019 Jun;71:40-42. - PMID 30877872 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies, Monoclonal, Murine-Derived |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Rituximab |2 NLM | |
| 650 | 7 | |a 4F4X42SYQ6 |2 NLM | |
| 700 | 1 | |a Tavakolpour, Soheil |e verfasserin |4 aut | |
| 700 | 1 | |a Mahmoudi, Hamidreza |e verfasserin |4 aut | |
| 700 | 1 | |a Noormohammadpour, Pedram |e verfasserin |4 aut | |
| 700 | 1 | |a Balighi, Kamran |e verfasserin |4 aut | |
| 700 | 1 | |a Daneshpazhooh, Maryam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunopharmacology and immunotoxicology |d 1996 |g 42(2020), 1 vom: 01. Feb., Seite 56-58 |w (DE-627)NLM012646636 |x 1532-2513 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2020 |g number:1 |g day:01 |g month:02 |g pages:56-58 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/08923973.2020.1717526 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2020 |e 1 |b 01 |c 02 |h 56-58 | ||